| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067148 Levothyroxine sodium and liothyronine sodium in solid form with microcrystalline cellulose; treating hypothyroidism and thyroid hormone replacement therapy |
| 06/27/2006 | CA2184889C Chemical castration |
| 06/22/2006 | WO2006065968A2 The uses of estrogen beta agonists to treat cognitive diseases |
| 06/22/2006 | WO2006064277A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064263A1 Silicon compounds and their use |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006003013A3 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135606 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 06/22/2006 | US20060135593 N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/22/2006 | US20060135583 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060134119 Drugs containing galectin 9 |
| 06/22/2006 | CA2590881A1 Silicon compounds and their use |
| 06/22/2006 | CA2590877A1 Silicon compounds and their use |
| 06/22/2006 | CA2590258A1 Novel uses for estrogen beta agonists |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671649A1 Remedy for diabetes |
| 06/21/2006 | EP1670777A1 Use of 8-prenylnaringenin for hormone replacement therapy |
| 06/21/2006 | EP1670483A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 06/21/2006 | EP1670444A2 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 06/21/2006 | EP1265617B1 Novel topical oestroprogestational compositions with systemic effect |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1173163B1 Pharmaceutical compositions of tetrac and methods of use thereof |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | CN1791603A Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791570A Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 06/21/2006 | CN1791424A Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260215C Antagon of endostadin receptor pyrazole carboxylic acids |
| 06/21/2006 | CN1259908C Hydrolysis-optimized liplid emulsions and use thereof |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064120 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates |
| 06/20/2006 | US7064104 Methods of managing the symptoms of premenstrual syndrome |
| 06/15/2006 | WO2006062104A1 Bacillus macroides strain and food using the same |
| 06/15/2006 | WO2006060873A1 Method for restoring reproductive function |
| 06/15/2006 | WO2006048911A3 Pharmaceutical or nutraceutical compositions containing chromium or iron complexes of alpha-lipoic acid |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128722 Indoles useful in the treatment of androgen-receptor related diseases |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems |
| 06/14/2006 | EP1669350A1 Novel piperidine derivative |
| 06/14/2006 | EP1669073A2 Fulvestrant formulation |
| 06/14/2006 | EP1668119A2 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667678A1 Animal feed composition |
| 06/14/2006 | EP1667521A2 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1438336B1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1267851B1 Compositions comprising carotenoids and use thereof for preventing hormone induced adverse effects |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1143963B1 Multiparticulate bisoprolol formulation |
| 06/14/2006 | EP1135115B1 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | DE102004059880A1 Stabiles, hormonhaltiges (Zwischen-)Produkt Stable, containing hormones (intermediate) product |
| 06/14/2006 | CN1787825A External patch containing estrogen and/or progestogen |
| 06/14/2006 | CN1787820A Composition for improving cognition and memory |
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/14/2006 | CN1259069C Selective moderator composition of estrogen receptor and preparation process thereof |
| 06/14/2006 | CN1259046C Soyisoflavone soft capsule and its preparation technology |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 06/13/2006 | US7060259 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 06/13/2006 | CA2302601C Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/13/2006 | CA2155434C Prohormone convertase transformed cells and polypeptide synthesis |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase |
| 06/08/2006 | WO2006013427A3 Treatment of ccr2 mediated diseases or disorders |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122244 Hypoglycemic agents; antidiabetic agentys; side effect reduction; cardiovascular disorders; anticancer agents |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122204 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/08/2006 | US20060122202 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121132 TNF-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/08/2006 | US20060121115 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2584136A1 Enhancer of the effect of adrenocorticoid, comprising gum arabic |